# Compass Therapeutics, Inc.: Form SC 13D/A, filed Nov 9, 2021

- Company: [Compass Therapeutics, Inc.](/companies/cmpx.md) (CIK 1738021)
- Form: SC 13D/A
- Filed: 2021-11-09
- Accepted by EDGAR: Nov 9, 2021, 17:30 ET
- Period: not reported
- Accession: 0000947871-21-001157
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1738021/000094787121001157/ss606127_sc13da.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1738021/000094787121001157/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1738021/000094787121001157/ss606127_sc13da.htm

Filed Nov 9, 2021.
Source: SEC EDGAR, the filing index for accession 0000947871-21-001157. Last ingested by Listed: Nov 10, 2026, 16:45 ET. No prices; not investment advice.
